ProfileGDS5678 / 1435477_s_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 112.433799
GSM967853U87-EV human glioblastoma xenograft - Control 212.470199
GSM967854U87-EV human glioblastoma xenograft - Control 312.49699
GSM967855U87-EV human glioblastoma xenograft - Control 412.714799
GSM967856U87-EV human glioblastoma xenograft - Control 512.680699
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 112.712899
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 212.393999
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 312.512999
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 412.263799
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 112.280899
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 212.660799
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 312.765299
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 412.632199
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 512.582699